News & updates

LUMC Global is looking for a PhD Candidate/Physician-researcher Obstetrics

Created on:


September 23, 2021

LUMC Global has set out to stimulate international connections in (bio)medical research and education to contribute to global healthcare. Setting up several PhD projects has been one of the key elements in doing this and we’re very proud we’ve been able to set up as many as eight different PhD projects. We are now looking for a Global PhD candidate in Obstetrics in a collaborative projects with Karolinska Institutet, Sweden and UZ Leuven, Belgium.

What you’ll do

Monochorionic diamniotic twin pregnancies, sharing one placenta with blood vessel anastomosis have a high risk of pregnancy complications. Selective fetal growth restriction (sFGR) occurs when there is unequal placenta sharing. A small placenta shares results in abnormal blood flows and less growth. The growth restricted fetus is at risk for fetal demise, and because of the anastomosis between the twins the other twin is at risk too for fetal demise or severe neurodevelopmental damage. The pathogenesis, diagnostic criteria, management, and outcome of sFGR are not well-established yet.

With this unique collaboration between the LUMC, UZ Leuven, and Karolinska we aim for an important milestone in the research on sFGR. This is where you come in! You will design, execute, and coordinate the collection of data, which you will then process, analyze and interpret. You conduct literature reviews, and give written and oral reports on the outcomes of your research.

Read the full vacancy here!


More news & updates

Background Image Of A Scientist Recording Test Results In A Lab

Janssen COVID-19 vaccine approved for use in EU on March 11

March 11, 2021

The Janssen-Cilag International N.V COVID-19 vaccine has received authorization for emergency use by the European Medicines Agency (EMA) on March 11. Developed with fundamental support from the Molecular Virology group of the Leiden University Medical Centre (LUMC), it is the fourth vaccine to be administered in the European Union. The Netherlands has ordered more than 11 million vaccine doses.

Studying abroad during a pandemic

July 15, 2021

For many students from the LUMC’s academic programmes, studying abroad is an indispensable experience. Doing part of your studies abroad is a special experience, not only because of the sense of adventure of being abroad, also to develop a broader perspective on Life Sciences & Health, a highly international field. So, you can imagine the LUMC’s International Office’s struggle to have to tell students ‘no’ for a study experience abroad in the midst of the corona pandemic. In addition, the many lockdowns worldwide increased the workload dramatically for the International Office. Evelien Hack, Head of the International Office and Sandra van Deursen, senior administrative assistant, share how corona has impacted studying abroad.

Body cells under a microscope. A good illustration as a representation of research of stem cells, cellular therapy and regeneration and many other concepts. 3D illustration

LUMC and Ixaka announce collaboration to advance cell therapy development

March 30, 2021

The Leiden University Medical Center (LUMC) and Ixaka Ltd. have announced a research collaboration on 30 March 2021, to better understand REX-001, Ixaka’s lead cell therapy product. The project will be led by Professor Paul Quax, Head of Experimental Vascular Surgery at the LUMC, to support accelerated development of REX-001 in Phase III clinical trials for the treatment of chronic limb-threatening ischemia (CLTI).

Stay up to date with news, inspirations and events.

© LUMC Global. All rights reserved. Website door philogirl

Contact

Social